Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkey...
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
About this item
Full title
Author / Creator
Hutson, Christina L. , Kondas, Ashley V. , Mauldin, Mathew R. , Doty, Jeffrey B. , Grossi, Irma M. , Morgan, Clint N. , Ostergaard, Sharon Dietz , Hughes, Christine M. , Nakazawa, Yoshinori , Kling, Chantal , Martin, Brock E. , Ellison, James A. , Carroll, Darin D. , Gallardo-Romero, Nadia F. and Olson, Victoria A.
Publisher
United States: American Society for Microbiology
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Society for Microbiology
Subjects
More information
Scope and Contents
Contents
Preparedness activities against highly transmissible viruses with high mortality rates have been highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic. Smallpox, caused by variola virus (VARV) infection, is highly transmissible, with an estimated 30% mortality.
Smallpox, caused by
Variola virus
(VARV), was eradicated...
Alternative Titles
Full title
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6de151897e92475986235b8d68fe984b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6de151897e92475986235b8d68fe984b
Other Identifiers
ISSN
2379-5042
E-ISSN
2379-5042
DOI
10.1128/mSphere.00927-20
